Join AlphaMaven

The Home Of Private Equity

Register For Free Learn More Contact Us

Most Visited Alternative Investment Industry Website. Over 50,000 visitors per month

Private Equity Dashboard:

Click to subscribe to our Free Daily Newsletter

Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

Space SPAC Draws SEC Enforcement Action for Allegedly Misleading Disclosures and Due Diligence Failures
2yrs ago Hedge Fund Private Equity privateequitylitigation Views: 552

As one of the first of an expected series of potential enforcement actions, the SEC has brought an enforcement action against a SPAC and its major participants, highlighting enhanced regulatory scrutiny of SPACs and underscoring the importance of following appropriate diligence and other practices in the de-SPAC process. Given the rapid growth in this sector over the past few years, the SEC’s Enforcement Division has a working group focused on the area, combined with staff guidance and remarks earlier this year on SPACs relating to the use of projections, accounting methodologies and celebrity involvement with SPACs. With this in mind, this client alert offers a few practice considerations for fund managers in the area.

Read the full client alert here.


Today's Private Equity Headlines:

Most popular| Most recent
FEATURED MEMBER POST
Andrea Alms Video:  Money In Motion 98 - Radiation Therapy Market
Private Equity BrookDell Partners #Video
Regulatory Minutes: Part 3
1w ago Private Equity akingump
Four Lessons For Health Systems From The Private Equity Playbook (Video) - M&A/Private Equity - United States - Mondaq News Alerts
1w ago Private Equity mondaq
Esprit in Talks With Private Equity Firm for Potential Investments - The Wall Street Journal
1w ago Private Equity wsj
How Justin Ishbia Built One Of America's Most Successful Private Equity Firms - Forbes
1w ago Private Equity forbes
Federal concerns mount over private equity hospital staffing, patient care in S. Colorado - KRDO
1w ago Private Equity krdo
AIP increases AUM via Phoenix
1w ago Private Equity airfinancejournal
Tech M&A Reigns Supreme In Q1 After Rare Hiccup In Q4
1w ago Private Equity law360
Fintech Investment Biz To Go Public Via $700M SPAC Merger
1w ago Private Equity law360
House GOP To Air Measure Rejecting SEC Climate Rule
1w ago Private Equity law360
Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
Sign Up Now
CREATE A FREE MEMBERSHIP
View Private Equity Listings
AlphaMaven Daily Indices
Apr MTD ROR
AlphaMaven Private Equity Index:
3.8%
- more -
SPONSORED BY
Be Seen - Advertise With Us
Click to Discuss
FEATURED MEMBER POSTS
Andrea Alms Video:  Money In Motion 98 - Radiation Therapy Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 97 - The Chemotherapy Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 96 - Bone Marrow Transplantation Market
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 100 - Cancer Market Wrap-Up
- posted by: BrookDell Partners
Andrea Alms Video:  Money In Motion 101 - Deep Dive - Immunotherapy Cancer Market
- posted by: BrookDell Partners
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.